Latest News
Conference Coverage
Relapsing-remitting MS best treated within 6 months of onset
BERLIN – Disease-modifying treatment for relapsing-remitting multiple sclerosis decreased the risk of disability progression at 12 months by 28...
Conference Coverage
Mood disorders worsen multiple sclerosis disability
BERLIN – Men with MS and either depression or bipolar disorder were at especially higher risk of worsening disability.
Conference Coverage
Revamped MS criteria boost pediatric diagnoses
BERLIN – Oligoclonal bands and absence of anti-MoG antibodies are useful clinical markers during a diagnostic work-up.
Conference Coverage
No elevated cancer risk with MS therapies in COMBAT-MS data
BERLIN – No elevations were seen in overall cancer rates, or in breast cancer rates.
From the Journals
Virus-specific T-cell infusion may resolve progressive multifocal leukoencephalopathy
One patient fully recovered and a second improved but had speech and mobility problems.
Video
Planning for ventilator-dependent patients during natural disasters
SAN ANTONIO – Ventilator-dependent patient are especially vulnerable during natural disasters.
Video
ADVENT-HF early results: High ASV compliance, no safety concerns
SAN ANTONIO – Compliance with adaptive servo ventilation was greater in the ADVENT-HF trial.
From the Journals
Modeling favors immediate AED after unprovoked first seizure
The model favored treatment of a patient with a single unprovoked seizure who did not meet the ILAE epilepsy definition.
From the Journals
Short-term NSAIDs appear safe for high-risk patients
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients...
FDA/CDC
FDA approves new treatment for hereditary transthyretin-mediated amyloidosis
Inotersen inhibits the production of amyloid in patients with the rare disorder.
Feature
Telehealth: States broaden options for locations, providers
More states are expanding telehealth locations and broadening the pool of telemedicine providers, while fading out in-person requirements.